Concurrent users
Unlimited
Authorized users
Authorized users
Document Delivery Supplied
Can lend chapters, not whole ebooks
Title
Polymyxin antibiotics : from laboratory bench to bedside / Jian Li, Roger L. Nation, Keith S. Kaye, editors.
ISBN
9783030163730 (electronic book)
3030163733 (electronic book)
9783030163716
3030163717
9783030163716
9783030163723
3030163725
Published
Cham : Springer, [2019]
Copyright
©2019
Language
English
Description
1 online resource : illustrations.
Other Standard Identifiers
10.1007/978-3-030-16373-0 doi
10.1007/978-3-030-16
Call Number
RM267 .P65 2019eb
Dewey Decimal Classification
615.7/922
Summary
It is our wish that readers discover the importance of polymyxin structure in relation to the mechanisms of activity, resistance and toxicity. We emphasized that reliable analytic methods for polymyxins are critical when investigating their pharmacokinetics (PK) and pharmacodynamics (PD). The complicated dose definitions and different pharmacopoeial standards have already compromised the safe use of polymyxins in patients. Therefore, informed by the latest pharmacological information, scientifically-based dosing recommendations have been proposed for intravenous polymyxins. Considering the PK/PD limitations and potential development of resistance, polymyxin combinations are encouraged; however, the current literature has not shown definite microbiological benefits, possibly because most clinical studies to date overlooked key PK/PD principles. Nephrotoxicity is the major dose-limiting factor and it is imperative to elucidate the mechanisms and develop novel approaches to minimize polymyxin-associated toxicities. In addition, the anti-endotoxin effect of polymyxins supports their clinical use to treat Gram-negative sepsis. Fortunately, the discovery of new-generation polymyxins with wider therapeutic windows has benefited from the latest achievements in polymyxin research.
Bibliography, etc. Note
Includes bibliographical references and index.
Access Note
Access limited to authorized users.
Digital File Characteristics
text file PDF
Source of Description
Online resource; title from PDF title page (SpringerLink, viewed August 28, 2019).
Series
Advances in experimental medicine and biology ; v. 1145.
Available in Other Form
Print version: 9783030163716
Overview
Multidrug resistant Gram-negative pathogens: the urgent need for 'old' polymyxins
Discovery, antibacterial spectrum and chemistry
Mechanisms of antibacterial activity
Mechanisms of resistance
Bioanalysis and stability of polymyxins
In vitro pharmacodynamics and PK/PD in animals
Antibacterial susceptibility breakpoints
Labeling of parenteral products of colistin methanesulfonate
Meta-analysis of polymyxin use in patients
Clinical use of colistin
Clinical use of polymyxin B
Pharmacokinetics, pharmacodynamics, toxicodynamics and dosing recommendations
Rational combinations with other antibiotics
Toxicities in patients: management and mechanisms
Antiendotoxin effect
Discovery of novel polymyxin-like antibiotics
Conclusion.
